EXHIBIT 10.2 CONSENT TO ASSIGNMENT AGREEMENTConsent to Assignment Agreement • August 14th, 2000 • Connetics Corp • Pharmaceutical preparations • California
EX-10.66 10 d843160dex1066.htm EX-10.66 CONSENT TO ASSIGNMENT AGREEMENT BETWEEN CONNETICS AND INTERMUNE PHARMACEUTICALS, INC. JUNE 23, 2000Consent to Assignment Agreement • May 5th, 2020 • California
THIS CONSENT TO ASSIGNMENT AGREEMENT (this “Agreement”) is made effective and entered into as of June 23, 2000 (the “Effective Date”) by and between GENENTECH, INC., a Delaware corporation, with a principal place of business at 1 DNA Way, South San Francisco, California 94080 (“Genentech”), CONNETICS CORPORATION, a Delaware corporation, with a principal place of business at 3400 Bayshore Road, Palo Alto, California 94303 (“Connetics”) and INTERMUNE PHARMACEUTICALS, INC., a Delaware corporation, with a principal place of business at 1710 Gilbreth Road, Suite 301, Burlingame, CA 94010 (“InterMune”). Genentech, Connetics and InterMune may be referred to herein as a “Party” or collectively as the “Parties.”
CONSENT TO ASSIGNMENT AGREEMENTConsent to Assignment Agreement • October 27th, 2010 • Zogenix, Inc. • Pharmaceutical preparations • California
This Consent to Assignment Agreement (this “Consent”), dated for reference purposes August 29, 2008, is made by R.B. INCOME PROPERTIES, a California limited partnership, (“Landlord”), to VERUS PHARMACEUTICALS, INC., a Delaware corporation (“Assignor”), and ZOGENIX, INC., a Delaware corporation (“Assignee”).
CONSENT TO ASSIGNMENT AGREEMENTConsent to Assignment Agreement • May 30th, 2012 • California
This Consent to Assignment Agreement (“Consent”) is made as of June 6, 2012, by THE NAPA SANITATION DISTRICT, a California Special District (“District”), to THE PETER A. AND VERNICE H. GASSER FOUNDATION, a California corporation (“Assignor”), and GASSER SOUTH, LLC, a Delaware limited liability company (“Assignee”).
CONSENT TO ASSIGNMENT AGREEMENTConsent to Assignment Agreement • March 12th, 2021
, 20 by and among (“Assignor” or “Licensor”), (“Assignee/Licensee”) and MOMS FOR MOMS COMMUNITIES, LLC, a Colorado limited liability company (“MfMC”).
1 2 1. Consent to Assignment. Subject to the terms and conditions specified in this Consent and the execution and delivery of the Networks SNDA, the documents referred to in items 2, 3 and 4 of Exhibit C hereof, the Cushman Agreement (defined in...Consent to Assignment Agreement • February 11th, 1998 • Network Associates Inc • Services-prepackaged software • California
CONSENT TO ASSIGNMENT AGREEMENTConsent to Assignment Agreement • March 11th, 2013 • Ambassadors Group Inc • Services-educational services • Missouri
This CONSENT TO ASSIGNMENT AGREEMENT is made this 3rd day of August, 1995 by and among PEOPLE TO PEOPLE INTERNATIONAL (“PTPI”), a Missouri non-profit corporation, INTERNATIONAL AMBASSADOR PROGRAMS, INC. (“IAP”), a Washington corporation, AMBASSADORS INTERNATIONAL, INC. (“Ambassadors”), a Delaware corporation, and AMBASSADOR PROGRAMS, a Delaware corporation and a wholly-owned subsidiary of Ambassadors (“Newco”).
CONSENT TO ASSIGNMENT AGREEMENT BETWEEN CONNETICS AND INTERMUNE PHARMACEUTICALS, INC. JUNE 23, 2000Consent to Assignment Agreement • June 26th, 2014 • Vidara Therapeutics International LTD • California
THIS CONSENT TO ASSIGNMENT AGREEMENT (this “Agreement”) is made effective and entered into as of June 23, 2000 (the “Effective Date”) by and between GENENTECH, INC., a Delaware corporation, with a principal place of business at 1 DNA Way, South San Francisco, California 94080 (“Genentech”), CONNETICS CORPORATION, a Delaware corporation, with a principal place of business at 3400 Bayshore Road, Palo Alto, California 94303 (“Connetics”) and INTERMUNE PHARMACEUTICALS, INC., a Delaware corporation, with a principal place of business at 1710 Gilbreth Road, Suite 301, Burlingame, CA 94010 (“InterMune”). Genentech, Connetics and InterMune may be referred to herein as a “Party” or collectively as the “Parties.”
CONSENT TO ASSIGNMENT AGREEMENTConsent to Assignment Agreement • March 18th, 2010 • Li3 Energy, Inc. • Miscellaneous manufacturing industries
THIS CONSENT TO ASSIGNMENT AGREEMENT (this “Agreement”) is entered into as of February 16, 2010 (the “Effective Date”), by and among Geoxplor Corp., a Nevada corporation (“Geo”), Next Lithium Corp., a Province of Ontario corporation (“Lithium”), Next Lithium (Nevada) Corp., a Nevada corporation (“Lithium US” and together with Lithium, “Next”), and Li3 Energy, Inc., a Nevada corporation (“Li3”).
CONSENT TO ASSIGNMENT AGREEMENT BY AND BETWEEN THEConsent to Assignment Agreement • April 4th, 2012
This consent to assignment agreement (“Consent Agreement”) is made and entered into on this day of , 2012 (“Effective Date”), by and between the City of Redwood City, California, a charter city and municipal corporation of the State of California, with its principal place of business located at 1017 Middlefield Road, Redwood City California 94063 (“City”) and Badawi & Associates, a Corporation, with its principal place of business located at 180 Grand Avenue, Suite 955, Oakland, CA 94612 (“Badawi & Associates” or “Assignee”). City and Badawi & Associates may be individually referred to in this Consent Agreement as a “Party” or collectively as the “Parties” or the “Parties to this Consent Agreement.”
CONSENT TO ASSIGNMENT AGREEMENTConsent to Assignment Agreement • April 5th, 2005 • Ev3 Inc.
This Consent to Agreement ("Consent") is entered into by and between ev3, Inc., a Delaware corporation ("ev3"), Microvena Corporation, a Minnesota corporation (Microvena"), and SurModics, Inc., a Minnesota corporation ("SurModics").
CONSENT TO ASSIGNMENT AGREEMENTConsent to Assignment Agreement • August 5th, 2009 • Doral Energy Corp. • Crude petroleum & natural gas • Nevada
CONSENT TO ASSIGNMENT AGREEMENTConsent to Assignment Agreement • September 3rd, 2010 • Zogenix, Inc. • Pharmaceutical preparations • California
This Consent to Assignment Agreement (this “Consent”), dated for reference purposes August 29, 2008, is made by R.B. INCOME PROPERTIES, a California limited partnership, (“Landlord”), to VERUS PHARMACEUTICALS, INC., a Delaware corporation (“Assignor”), and ZOGENIX, INC., a Delaware corporation (“Assignee”).
